Actelion publishes Annual Report 2009
(Thomson Reuters ONE) -
Actelion Pharmaceuticals Ltd / Actelion publishes Annual Report 2009 processed and transmitted by Hugin AS. The issuer is solely responsible for the content of this announcement.
ALLSCHWIL/BASEL, SWITZERLAND - 18 February 2010 -Actelion Ltd (SIX: ATLN) today
announced that is has published its Annual Report 2009 on its website. All
relevant documents (full year 2009 media release, Annual Report 2009 in brief
and in detail, Financial Statements) are accessible at the Results Day Center:
http://www.actelion.com/en/investors/results-day-center/index.page?
corporate website www.actelion.com
###
Actelion Ltd
Actelion Ltd is a biopharmaceutical company with its corporate headquarters in
Allschwil/Basel, Switzerland. Actelion's first drug Tracleer®, an orally
available dual endothelin receptor antagonist, has been approved as a therapy
for pulmonary arterial hypertension. Actelion markets Tracleer® through its own
subsidiaries in key markets worldwide, including the United States (based in
South San Francisco), the European Union, Japan, Canada, Australia and
Switzerland. Actelion, founded in late 1997, is a leading player in innovative
science related to the endothelium - the single layer of cells separating every
blood vessel from the blood stream. Actelion's over 2,200 employees focus on the
discovery, development and marketing of innovative drugs for significant unmet
medical needs. Actelion shares are traded on the SIX Swiss Exchange (ticker
symbol: ATLN) as part of the Swiss blue-chip index SMI (Swiss Market Index
SMI®).
For further information please contact:
Roland Haefeli
Vice President, Head of Investor Relations & Public Affairs
Actelion Pharmaceuticals Ltd, Gewerbestrasse 16, CH-4123 Allschwil
+41 61 565 62 62
+1 646 737 49 72
http://www.actelion.com
[HUG#1385862]
--- End of Message ---
Actelion Pharmaceuticals Ltd
Gewerbestrasse 16 Allschwil Switzerland
WKN: 936767;ISIN: CH0010532478;
Press Release PDF: http://hugin.info/131801/R/1385862/344627.pdf
Unternehmensinformation / Kurzprofil:
Datum: 18.02.2010 - 08:48 Uhr
Sprache: Deutsch
News-ID 12662
Anzahl Zeichen: 0
contact information:
Town:
Allschwil
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 298 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Actelion publishes Annual Report 2009"
steht unter der journalistisch-redaktionellen Verantwortung von
Actelion Pharmaceuticals Ltd (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
